Moneycontrol Be a Pro
Get App
Last Updated : Nov 18, 2019 04:12 PM IST | Source:

3-Point Analysis | Sequent Scientific Q2 review

Sakshi Batra does a 3-Point Analysis of the earnings fine-print and the outlook on Sequent Scientific.

Sequent Scientific posted an interesting set of Q2 numbers that reflect a strong show for Active Pharmaceutical Ingredient.

Sales of the company grew by 12.9 percent year on year, driven by growth in APIs, which constitute 34 percent of quarterly sales. Formulations too jumped 7.7 percent on constant currency basis even as a strong improvement in Turkey was partially offset by performance in Europe and India.

Sakshi Batra does a 3-Point Analysis of the earnings fine-print and the outlook on the company.

Watch the video for more.

Are you happy with your current monthly income? Do you know you can double it without working extra hours or asking for a raise? Rahul Shah, one of the India's leading expert on wealth building, has created a strategy which makes it possible... in just a short few years. You can know his secrets in his FREE video series airing between 12th to 17th December. You can reserve your free seat here.
First Published on Nov 18, 2019 04:11 pm
Follow us on
Available On